First Tracks launched April 20th with a two-year cash-runway to advance ANB033 through celiac disease and eosinophilic esophagitis Phase 1b data and plans to initiate Phase 2 trials across four indica ...
First Tracks launched April 20th with a two-year cash-runway to advance ANB033 through celiac disease and eosinophilic ...
Caitlin Havener on MSN
Understanding the benefits of fermented foods for digestion
Walk into almost any grocery store today and you'll notice the shelves stocked with kimchi, kefir, kombucha, and an ...
Dublin mum battles rare cancer in Barcelona as family launches fundraiser READ THE FULL STORY: Dublin mum forced to seek ...
A recent Views & Comments article published in Engineering highlights advances in repurposing influenza viruses as flexible ...
Three exceptional Simon Fraser University researchers have been named new and renewed Canada Research Chairs. Announced today ...
During its 175th anniversary year, Erbe Elektromedizin GmbH highlights its continued commitment to healthcare innovation with ...
Targeted dietary therapies can induce remission in 50%-80% of IBD patients; discover which protocols — EEN, CDED, and whole ...
A first-in-human trial of a robotic colonoscopy shows the system can perform all functions of a colonoscope with promising ...
Nasal vaccines target mucosal surfaces in the nose to block respiratory infections early Traditional injected vaccines ...
Epirium Bio Inc. (Epirium), a clinical-stage biopharmaceutical company advancing medicines for neuromuscular, inflammatory, and fibrotic diseases, is presenting new translational data on its oral ...
In the rapidly evolving field of immunomodulation, few compounds have garnered as much interest for their precision as the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results